coronavirus « Search Results « Science and Enterprise

Nasal Spray Vaccines Get CEPI, NIH Funding

By Alan, on October 6th, 2022%

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

Challenge Seeks Animal-Free Testing for Precision Meds.

By Alan, on September 20th, 2022%

A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine. . . . → Read More: Challenge Seeks Animal-Free Testing for Precision Meds.

Infographic – Fewer in US See Covid-19 Threat

By Alan, on July 30th, 2022%

The percentage of Americans viewing Covid-19 as a major threat to public health is declining, with a majority now saying the disease is a minor or no threat at all. . . . → Read More: Infographic – Fewer in US See Covid-19 Threat

Small Biz Grant Funds Non-Viral Gene Editing Delivery

By Alan, on July 26th, 2022%

National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery

Trial Shows Oral Covid-19 Vaccine Produces Antibodies

By Alan, on July 20th, 2022%

A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year. . . . → Read More: Trial Shows Oral Covid-19 Vaccine Produces Antibodies

Human Organoids Show Drug Activity in Lab Animals

By Alan, on July 7th, 2022%

A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats. . . . → Read More: Human Organoids Show Drug Activity in Lab Animals

Infographic – US Workers Returning to Work

By Alan, on June 4th, 2022%

New data from the U.S. Bureau of Labor Statistics, displayed in chart form last week, indicate the work-from-home era may be closing. . . . → Read More: Infographic – US Workers Returning to Work

AI Drug Company Creating Covid-19 Therapy for Rapid Delivery

By Alan, on May 24th, 2022%

A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced. . . . → Read More: AI Drug Company Creating Covid-19 Therapy for Rapid Delivery

Venture Investor Funds Cell Therapy Targeting Tech

By Alan, on May 19th, 2022%

A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases. . . . → Read More: Venture Investor Funds Cell Therapy Targeting Tech

Preclinical Tests Show Antibody Stops Covid-19 Variants

By Alan, on April 13th, 2022%

Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise